José Villar,Shabina Ariff,Robert B Gunier,Ramachandran Thiruvengadam,Stephen Rauch,Alexey Kholin,Paola Roggero,Federico Prefumo,Marynéa Silva do Vale,Jorge Arturo Cardona-Perez,Nerea Maiz,Irene Cetin,Valeria Savasi,Philippe Deruelle,Sarah Rae Easter,Joanna Sichitiu,Constanza P Soto Conti,Ernawati Ernawati,Mohak Mhatre,Jagjit Singh Teji,Becky Liu,Carola Capelli,Manuela Oberto,Laura Salazar,Michael G Gravett,Paolo Ivo Cavoretto,Vincent Bizor Nachinab,Hadiza Galadanci,Daniel Oros,Adejumoke Idowu Ayede,Loïc Sentilhes,Babagana Bako,Mónica Savorani,Hellas Cena,Perla K García-May,Saturday Etuk,Roberto Casale,Sherief Abd-Elsalam,Satoru Ikenoue,Muhammad Baffah Aminu,Carmen Vecciarelli,Eduardo A Duro,Mustapha Ado Usman,Yetunde John-Akinola,Ricardo Nieto,Enrico Ferrazi,Zulfiqar A Bhutta,Ana Langer,Stephen H Kennedy,Aris T Papageorghiou

Abstract:Importance: Detailed information about the association of COVID-19 with outcomes in pregnant individuals compared with not-infected pregnant individuals is much needed. Objective: To evaluate the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with not-infected, concomitant pregnant individuals. Design, setting, and participants: In this cohort study that took place from March to October 2020, involving 43 institutions in 18 countries, 2 unmatched, consecutive, not-infected women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. Women and neonates were followed up until hospital discharge. Exposures: COVID-19 in pregnancy determined by laboratory confirmation of COVID-19 and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms. Main outcomes and measures: The primary outcome measures were indices of (maternal and severe neonatal/perinatal) morbidity and mortality; the individual components of these indices were secondary outcomes. Models for these outcomes were adjusted for country, month entering study, maternal age, and history of morbidity. Results: A total of 706 pregnant women with COVID-19 diagnosis and 1424 pregnant women without COVID-19 diagnosis were enrolled, all with broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Overweight early in pregnancy occurred in 323 women (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were at higher risk for preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27-2.43), severe infections (RR, 3.38; 95% CI, 1.63-7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13-8.10), maternal mortality (RR, 22.3; 95% CI, 2.88-172), preterm birth (RR, 1.59; 95% CI, 1.30-1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56-2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69-4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66-2.75). Fever and shortness of breath for any duration was associated with increased risk of severe maternal complications (RR, 2.56; 95% CI, 1.92-3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11-11.69). Asymptomatic women with COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00-1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01-2.63). Among women who tested positive (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18-3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66-1.85) was associated with increased risk for neonatal test positivity. Conclusions and relevance: In this multinational cohort study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications when pregnant women with and without COVID-19 diagnosis were compared. The findings should alert pregnant individuals and clinicians to implement strictly all the recommended COVID-19 preventive measures.

SARS-CoV-2 (COVID-19) infection in pregnant women: characterization of symptoms and syndromes predictive of disease and severity through real-time, remote participatory epidemiology

The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS)

Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review

Clinical characteristics, outcomes and persistent symptoms of pregnant women with COVID-19: A retrospective cohort study

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020

SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity

Pregnancy and postpartum outcomes in a universally tested population for SARS‐CoV‐2 in New York City: a prospective cohort study

SARS-CoV-2 infection elucidates features of pregnancy-specific immunity

SARS-CoV-2 infection in pregnant women assisted in a high-risk maternity hospital in Brazil: Clinical aspects and obstetric outcomes

Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis

Social Drivers of COVID-19 Disease Severity in Pregnant Patients

Clinical characteristics of pregnant women infected with Coronavirus Disease 2019 in China: a nationwide case-control study

Predictors of COVID-19 severity among pregnant patients

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission

Maternal outcomes and risk factors for COVID-19 severity among pregnant women

Variability in COVID-19 symptom presentation during pregnancy and its impact on maternal and infant outcomes across the pandemic

Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2

Clinical course of coronavirus disease-2019 in pregnancy